De-escalation of neoadjuvant therapy for HER2-positive early breast cancer: an overview
Ann Palliat Med
.
2020 Jul;9(4):1352-1357.
doi: 10.21037/apm-20-1035.
Epub 2020 May 25.
Authors
Gustavo Werutsky
1
,
Mahira Lopes Rosa
2
Affiliations
1
Latin American Cooperative Oncology Group, Porto Alegre, Brazil. gustavo.werutsky@lacog.org.br.
2
Latin American Cooperative Oncology Group, Porto Alegre, Brazil.
PMID:
32527121
DOI:
10.21037/apm-20-1035
No abstract available
Publication types
Review
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Breast Neoplasms* / drug therapy
Chemotherapy, Adjuvant
Genes, erbB-2
Humans
Neoadjuvant Therapy*
Treatment Outcome